Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY® (fremanezumab-vfrm) Injection Significantly Reduced Migraine and Depression Symptoms in Patients
Ajovy, one of four newly FDA approved migraine preventatives. Close up of product in the box Stock Photo - Alamy